A fundamental question in systems biology addresses the issue of how flexibility is built into modulatory networks such that they can produce context dependent responses. Here we examine flexibility in the serotonin (5-HT) response system that modulates the cycle frequency (cf) of a rhythmic motor output. We found that depending upon the preparation, the same 5min bath application of 5-HT to the pyloric network of the California spiny lobster, Panulirus interruptus, could produce a significant increase, decrease or no change in steady state cf relative to baseline. Interestingly, the mean circuit output was not significantly different among preparations prior to 5-HT application. We developed pharmacological tools to examine the preparation-to-preparation variability in the components of the 5-HT response system. We found that the 5-HT response system consisted of at least three separable components: A 5-HT 2 Pan -like component mediated a rapid decrease followed by a sustained increase in cf. A 5-HT 1 Pan -like component produced a small and usually gradual increase in cf. At least one other component associated with an unknown receptor mediated a sustained decrease in cf. The magnitude of the change in cf produced by each component was highly variable, so that when summed they could produce either a net increase, decrease or no change in cf depending upon the preparation. Overall, our research demonstrates that the balance of opposing components of the 5-HT response system determines the direction and magnitude of 5-HT induced change in steady state cf relative to baseline.
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Here we investigate the components of the 5-HT response system that control pyloric cycle frequency (cf) in the California spiny lobster. Application of 5-HT to individual preparations that appeared to be in the same state uncovered latent preparation-to-preparation variability in the network. We found that pyloric networks producing motor outputs with similar cfs could respond to 5-HT application with either an increase, decrease or no change in pyloric cf, depending upon the preparation. We then identified pharmacological tools to differentiate the actions of the two previously cloned and characterized crustacean receptors, 5-HT 2 and 5-HT 1 (Clark et al., 2004; Sosa et al., 2004; Spitzer et al., 2008) . Finally, we used these tools to define the components of the 5-HT response system and determine how each component contributes to the variability in a network's response to the same modulatory input.
.
Materials and Methods

Animals
Spiny lobsters, Panulirus interruptus, were obtained from Don Tomlinson Commercial Fishing (San Diego, CA) and maintained at 16 o C in continually filtered and aerated artificial seawater. Animals were fed once per week with raw shrimp. The number of shrimp added to the tank was 2-5 more than the number of lobsters in the tank, but no attempt was made to ensure that each lobster received food.
Chemicals and Cell lines
HEK293 cells, EMEM, horse serum, trypsin and penicillin/streptomycin were obtained from American Type Culture Collection (Mannassas, VA). DMEM was from Mediatech Inc. (Herndon, VA). Dialyzed fetal bovine serum (FBS), TRex cell line (293-TR), pDNA4/TO plasmid, blasticidin and zeocin were from Invitrogen (Carlsbad, CA). Cinanserin was obtained from Tocris (Ballwin, MO). All other chemicals were from Sigma (St. Louis, MO). For pharmacology experiments, fresh amine and agonist stock solutions (10 -1 M) were made in media or 50% ethanol, respectively. Two exceptions were tyramine which was made fresh as a 10 -2 M stock in media and methysergide which was made as a 10 -2 M stock in DMSO and stored at -20 o C. Antagonist drugs were made as 10 -2 M stock solutions in DMSO and stored at -20 o C. To test the effect of DMSO on deafferented preparations, we applied 5-HT for 5 min, washed out for 1 hr, applied DMSO for 5min and then DMSO+5-HT for 5min. In the absence of 5-HT, application of DMSO for 5 min did not produce a detectable change in cf (p>0.23, n=4, also see Fig. 5 ). Neither did DMSO application alter the steady-state 5-HT response. The 5-HT induced change from baseline (average of last ten cycles during 5min 5-HT application/average for last 10 cycles just before 5-HT application) was not significantly different in the absence (0.93+0.21) vs. presence of DMSO (0.96+0.24, p>0.71, n=3) .
Electrophysiological recordings
Spiny lobsters were anesthetized for at least 30min on ice after which the STNS was dissected out and pinned in a Sylgard lined Petri dish using standard techniques (Selverston et al. 1976) . The stomatogastric ganglion (STG) and a portion of the stomatogastric nerve (stn) were desheathed. The preparation was bathed in Panulirus saline consisting of (in mM) 479 NaCl, 12.8 KCl, 13.7 CaCl 2 , 39 Na 2 SO 4 , 10 MgSO 4 , 2 glucose, 4.99 HEPES, 5 TES at pH 7.4. All experiments were carried out at room temperature. Petroleum jelly (Vaseline) wells (1-2cm across) were built around the STG and around the desheathed portion of the stn. Both wells were 5 always tested for leaks with saline containing 0.005% Fast Green. The well around the STG was constantly perfused at 2ml/min with saline or drug solutions and tests with Fast Green prior to every experiment showed that the solution in the STG well was completely exchanged in less than 20s.
Extracellular recordings from the pyloric dilator nerve (pdn), medial ventricular nerve (mvn) and lateral ventricular nerve (lvn) were obtained with stainless steel pin electrodes and a differential AC amplifier (A-M Systems, Everett, WA) as previously described (Baro et al. 1997) . In some preparations, the activity of the PD neuron was monitored with intracellular somatic recordings using glass microelectrodes filled with 3M KCl (20-30 M ) and an Axoclamp 2B amplifier (Axon Instruments, Foster City, CA). In these cases, the PD was identified by the characteristic shape of its oscillation, by its timing in the motor pattern and by a 1:1 correlation between action potentials recorded intracellularly from the soma and extracellularly from the pdn.
After recording baseline activity for 10min, the saline solution in the stn well was exchanged for 1M sucrose to block descending neuromodulatory input. After 1hr in the sucrose block, experiments to determine the effects of 5-HT receptor agonists and antagonists were performed. For experiments to determine the effect of the agonist 1-(m-chlorophenyl)-piperazine (mCPP), 10µM 5-HT was applied for 5min and washed out for 1hr, followed by a 5min application of 100µM mCPP which was then washed out for 1hr. The antagonist (+)butaclamol (10µM) was then applied for 5min followed immediately by a 5min application of (+)butaclamol + mCPP. After another 1hr wash (+)butaclamol was applied for 5min followed by 5min of (+)butaclamol + 5-HT. The preparation was washed for a final 1h and the experiment was terminated. In some experiments, the order of 5-HT and mCPP application were reversed with no detectable difference in effect. For experiments involving only 5-HT and antagonists (cinanserin or (+)butaclamol), one hour after applying a sucrose block, 5-HT was applied for 5min and washed out for 1hr. The antagonist was then applied alone for 5min and then in combination with 5-HT for 5min followed by a 1hr wash. After application of one antagonist the experiment was terminated and the preparation was not used further. In several experiments we applied antagonist plus 5-HT before 5-HT only, however, we found that the antagonist effects did not appear to wash out between applications (i.e., both 5-HT applications produced a similar effect, which was not the case when the order was reversed.).
Electrophysiological data acquisition and analysis.
Data were acquired using a Digidata 1322A data acquisition board (Axon Instruments) and Axoscope software. The data were subsequently analyzed with DataView 4.7a (W.J. Heitler, University of St. Andrews, Scotland), Microsoft Excel and Matlab (MathWorks, Natick, MA). We measured agonist-and antagonist-induced changes in 2 parameters: pyloric cf and spikes per burst of the VD (ventricular dilator) neuron. One cycle was defined as the period extending from the first spike in one PD burst to the first spike in the following PD burst. The cf and number of VD spikes per cycle were first plotted as a function of time for each experiment.
Baseline cf was determined from 10 cycles just before application of a drug when the preparation was in a periodic state (i.e. 1hr after the sucrose block was applied or at the end of a 1hr wash period). The time course of the 5-HT effect could be divided into three quantifiable phases. As a measure of phase 1 we obtained the nadir, i.e., lowest cf (averaged for a 10sec window) during the first 50 sec in 5-HT. As a measure of phase 2 we obtained the peak maximal cf (averaged for a ten sec window) from 50 to 120sec of 5-HT application. As a measure of phase 3 (i.e. steady-state) we obtained the average cf during the last minute of 5-HT application.
Difference traces representing the 5-HT 2 Pan -like component of the 5-HT response system were produced by subtracting cf plots obtained in the presence of 5-HT and antagonist from those obtained in the presence of 5-HT and absence of antagonist. A script was written in Matlab to perform this function. The data accessed by the script are termed the row data. The result of the analysis is a curve called a trace average, with values assigned for 0.05min time steps. The trace average for a given set of row data was calculated using uniform 0.15 min time intervals and a sliding window that moved in increments of 0.05min. Examples of these analyses are shown in Fig. 6 . Each set of left and right panels in Fig. 6 represents the analyses for a single preparation. The left panels show two trace averages plotted on top of their respective row data. Consider a single left panel. The set of blue data points represents the instantaneous cf recorded during a 5min 5-HT application. These are the data that were processed by the script (i.e., the row data) in order to generate the trace average, which is shown as a blue line. The row data and trace average for the instantaneous cf obtained in the presence of 5-HT plus antagonist are similarly plotted in green. Now consider the corresponding right panel. The gold trace was obtained by subtracting the green trace average from the blue trace average. Therefore, the gold difference trace represents the change in cf mediated by activation of 5-HT 2 Pan -like receptors in that preparation. Baselines for the trace averages were arbitrarily set to zero prior to subtraction. Thus, at any given point in time, the 5-HT 2 Pan component is calculated to be: (f 5-HT -f 5-HT baseline ) -(f 5-HT+antagonist -f antagonist baseline ), where 5-HT baseline and antagonist baseline are defined in Fig. 4 and f = frequency. Figure  7B shows the mean of the 24 trace averages obtained in 5-HT + antagonist. The mean of the 24 difference traces is shown in Fig. 7C Statistical analyses were performed with Excel (Microsoft) and Prism (GraphPad) as indicated. The 3-D plots were generated with Sigmaplot (Systat). Unless otherwise indicated, means are followed by the standard error of the mean, and significance was judged to be p<0.05.
Assay of IP release in cells expressing 5-HT 2 Pan
5-HT 2 Pan was transiently expressed in HEK293 cell culture, and inositol phosphate (IP) release in cells expressing 5-HT 2 Pan was assayed using previously described protocols (Clark et. al., 2004; Spitzer et al., 2008) . Briefly, transiently transfected cells expressing 5-HT 2 Pan were split into wells on a 24-well plate with 1µCi/ml of 3 H-myoinositol (Amersham, Piscataway, NJ) and allowed to grow to 95-100% confluency over 48 hours. The cells were washed with fresh EMEM and then exposed to 10mM LiCl in EMEM for 20min at 37 o C. As applicable, antagonists were added to individual wells and allowed to incubate for an additional 10min. 5-HT or agonist drugs were added to test wells and cells were returned to 37 o C for 60min. The medium was removed and replaced with ice cold 20mM formic acid. Plates were then placed on ice for 30min. The cell lysate was collected and applied to AG1-X8 columns (BioRad, Hercules, CA) equilibrated with 20mM formic acid. The columns were washed with 50mM ammonium hydroxide followed by elution of inositol phosphates (IP) with 10ml of 1M ammonium formate/0.1M formic acid. The IP fraction was scintillation counted. Membranes attached to the wells were dissolved in 1M NaOH and scintillation counted as total phosphatidyl inositols (PI). Activation results are expressed as the fraction of radioactivity incorporated in IP over that in Page 6 of 44 IP+PI and normalized to activity observed in negative control (no drug) wells for every experiment. At least three independent experiments were performed for each drug.
cAMP concentration determinations in cells expressing 5-HT 1 Pan
5-HT 1 Pan was stably expressed in an inducible expression system and cyclic AMP levels were determined using a Direct cAMP kit (Assay Designs, Ann Arbor, MI) as previously described (Spitzer et al., 2008) . Briefly, stably transfected cells were plated in 24-well plates and allowed to grow to 100% confluency. The medium was replaced with 1ml of complete medium containing 1µg/ml tetracycline to induce expression of receptor protein. After 18-20hr the medium was replaced with 1ml of fresh DMEM containing 2.5mM 3-isobutyl-1-methylxanthine to block phosphodiesterase activity and plates were incubated for 10min. Antagonists were added to individual wells (if applicable) and allowed to incubate for an additional 10min. 5-HT or agonists and forskolin (250nM), a nonspecific activator of adenylyl cyclase, were then added to individual wells and left at 37 o C for 30min. The medium was removed and replaced with 0.5ml of 0.1M HCl containing 0.8% Triton X-100. Plates were shaken 30min at room temperature, the lysate collected, centrifuged 5min at 600g and the supernatant assayed for cAMP concentration using the Direct cAMP kit and protein concentration using a BCA Protein Assay Kit (Pierce, Rockford, Il). Data are presented as picomoles of cAMP per milligram of protein. At least three independent experiments were performed for each drug.
Heterologous expression system data analysis
Data for all pharmacology assays involving the heterologous expression systems were plotted and analyzed in GraphPad Prism v.4. Dose-response curves were fitted with a standard slope top-bottom or bottom-top dose-response curve to calculate EC/IC 50 and efficacy values. Unless otherwise indicated, means are followed by the standard error of the mean.
Results
5-HT application produced a stereotypic inhibition of VD but a variable change in cf
We began this study by establishing the variable actions of 5-HT on pyloric cf. The pyloric circuit in the STNS of Panulirus consists of 6 cell types interconnected by electrical and inhibitory chemical synapses (Fig. 1A) . The circuit is driven by a pacemaker ensemble consisting of a single AB pacemaker interneuron that is electrically coupled to two PD motoneurons. In addition, two follower motoneurons, VD (1 per ganglion) and LP (1 per ganglion), feed back onto the pacemaker kernel and play an important role in governing cf (Weaver and Hooper 2003) . Endogenous oscillations in the AB neuron and consequent activity of coupled and follower neurons give rise to an identifiable motor output that can be measured extracellularly on efferent motor nerves. We monitored the AB-PD pacemaker kernel with extracellular recordings from the pdn, a motor nerve that exclusively contains the two axons of the 2 PD neurons. VD was monitored with extracellular electrodes on the mvn, a motor nerve that exclusively contains the axons of the single VD and IC neurons (Fig. 1B, top) . Although the LP is also important in governing cf (Ayali and Harris-Warrick 1999; Beltz et al. 1984; Miller and Selverston 1982; Weaver and Hooper 2003; Mamiya and Nadim 2004) , and is directly inhibited by 5-HT (Flamm and Harris-Warrick 1986b) , LP was silent under our experimental conditions (see below) and not monitored in these studies.
Descending modulatory input can be blocked by placing a pool of sucrose on the single modulatory input nerve (stomatogastric nerve, stn). After an hour of sucrose block the pyloric 8 cycle stabilizes in a basal cycling state; the pacemaker kernel cycles weakly (Fig. 1B, middle) , VD firing is reduced (Fig. 1B, middle) and LP, PY (8 per ganglion) and IC neurons are silenced (not shown). Once endogenous neuromodulation is removed with the sucrose block (deafferented preparation), the effect of individual modulators such as 5-HT can be assessed. We used a 5min application of 5-HT to mimic neurohormonal transmission. This relatively short application was chosen to minimize the induction of long term effects, but still produce a steady state response. The concentration of 5-HT used in these studies (10µM) is likely to be several orders of magnitude higher than the normal hormonal concentration. Thus, the actions of neurohormonal 5-HT in vivo may not be exactly reproduced in this paper. Nevertheless, the use of this high concentration is appropriate here, as the goal of this study was to investigate the latent variability in a network's response to the same modulatory input.
Consistent with previous reports, we found that 5-HT altered the activity of both the pacemaker kernel and the VD neuron. Fig. 1B shows serial recordings of pdn and mvn activity from two representative preparations before sucrose block (top), 1hr after sucrose block (middle) and at the peak of the 5-HT effect (bottom). As expected, there was a sustained reduction in VD firing frequency throughout the 5min 5-HT application. The VD was inhibited by 100% from baseline in 27 of 28 experiments, and the remaining preparation showed a 95% decrease in firing frequency. On the other hand, a 5min application of 10µM 5-HT did not produce consistent alterations in cf. 5-HT could increase (Fig. 1B , left pdn traces), decrease (Fig. 1B , right pdn traces) or produce no change (not shown) in cf relative to baseline, where baseline was measured after the 1hr sucrose block, immediately before 10µM 5-HT application.
Fig . 1C emphasizes the variability in 5-HT effects on cf. The average cf for the last 10 cycles in 5-HT (i.e., steady state 5-HT) was plotted against the average for the last 10 cycles just prior to the addition of 5-HT (i.e., baseline) for every deafferented preparation examined (n=44). Each datum represents a single preparation and the standard error of the means. The diagonal line represents unity. Experiments in which 5-HT had no effect fall along the line; those where 5-HT induced increases or decreases in cf are represented by data points above or below the line, respectively. The average steady state 5-HT effect for all 44 preparations is plotted in Fig 1D. The representation of the data in this manner is deceptive as it suggests that 5-HT had no significant effect on pyloric cf, which is clearly not the case (Fig. 1C) .
The variable change in cf did not correlate with gender, molt stage, time/date or the presence/absence of a spermatophore. It was previously suggested that 5-HT could elicit an increase in cf when the LP was silent and a decrease when the LP cell was active (Beltz et al., 1984) . However, this did not seem to be the case in our hands. We obtained extracellular LP recordings from the lvn in 20 preparations. After descending modulatory input was removed with a sucrose block, the LP was silent in 17 preparations, and fired very weakly and irregularly in the remaining 3. Moreover, it was postulated that the cf decrease was due to LP inhibition of PD. Using 10 -6 M picrotoxin to supress glutamatergic transmission (Bidaut 1980) , and hence the LP to PD synapse, we still observed an increase or decrease in cf (n=3, data not shown) Interestingly, washout of 5-HT for 10min produced a significant increase in cf (Fig. 1D ). In order to determine whether the washout effect varied with regard to the 5-HT response, we first classified preparations according to their response. Preparations showing more than a 5% decrease in steady state 5-HT cf relative to baseline were called Class S for slower. These preparations showed a mean 48+7% decrease in cf over baseline (paired t-test p<10 -5 , n=21), with individual decreases ranging from ~12-100%. Preparations falling into Class F, for faster, showed a mean 26+6% increase in steady state 5-HT cf from baseline (paired t-test p=0.001, Page 8 of 44 n=17), and individual increases ranged from ~6-107%. Preparations displaying less than a 5% change were classified as NC, for no change. These preparations showed a mean 0.0+1.0% decrease in cf over baseline (paired t-test p>0.71, n=6), and changes ranged from a 4% decrease to a 3% increase. The 5-HT effect washed out immediately and completely for all Class S preparations, and then the effect reversed so that by 1hr of wash the cf (averages for last ten cycles of 1hr wash) had significantly increased by an average of 26+15% over the original baseline (Fig 2A) . Similarly, all Class F (Fig 2B) and NC (Fig. 2C) preparations showed a significant increase over baseline by a 1hr wash. Thus it appeared that the long-term washout effect was the same for all Classes of preparations regardless of their response to 5-HT.
To assess whether the increased baseline was evoked by 5-HT washout or experimental "drift", we recorded for the same length of time from 6 deafferented preparations that never received 5-HT. Plots of instantaneous cycle frequency vs. time showed that in the absence of 5-HT there was a slow steady increase in cf over the course of 70min (Fig 3A) . The average of the last10 cycles during the 1hr sucrose block represented baseline. Fig 2D illustrates that there was no significant increase in cf over baseline by 5min (i.e. the time corresponding to 5min in 5-HT); however, there was a significant increase over baseline at the time corresponding to the 1hr wash. These data suggest that 5-HT independent phenomena (e.g., lack of modulatory inputs) could at least partially underpin the changing baseline over the course of the experiment.
We were interested in whether the change in baseline cf over 1hr would alter a deafferented preparation's response to 5-HT. In several experiments (n=8) we applied 5-HT sequentially to a deafferented preparation: 5-HT was applied for 5min, washed out for 1hr and then reapplied for 5min (Fig 3B) . We observed that the average response to the first and second applications of 5-HT were not significantly different (average steady-state 5-HT/baseline = 0.58+0.15Hz, 1 st application vs. 0.54+0.14Hz, 2 nd application; paired t-test p=0.17, n=8); however, the second response was usually set atop a higher baseline. Importantly, these experiments make the point that 5-HT receptors respond in a like manner to serial 5min applications of 5-HT spaced at 1hr intervals (see below).
The three temporal phases of the 5-HT induced changes in cf
We next examined the time course of the 5-HT induced changes in cf by plotting the frequency of each pyloric cycle before, during and after 5-HT application (n=37). Six representative examples are shown in Fig. 3 ,C-H. In ~75% of the experiments ( Fig. 2C-F ) the time course could generally be described as having three phases: An immediate decrease within the first 50sec of 5-HT application (Phase 1), followed by a slow increase over the next 70 sec (Phase 2), which ended in an apparent steady state (Phase 3). The time course and absolute value of the peak within each phase varied according to the preparation. Once peak cf was reached in phase 2, it was either maintained or gradually reached a new apparent steady state (e.g. Fig. 3E vs. 3F). Cycle frequencies were fairly stable after 3min in 5-HT; however, steady state 5-HT effects varied greatly, such that the three aforementioned Classes of responses were observed (Fig. 3C , Class F; Fig. 3D ; Class S; Fig. 3E&F , Class NC). The remaining 25% of the experiments were atypical with regard to time course. These preparations either exhibited no significant response to 5-HT (not shown; Class NC), displayed a small, gradual, significant increase over baseline throughout 5-HT application ( Fig. 3G ; Class F) or showed a fairly dramatic, significant decrease relative to baseline, followed by an apparent steady state ( Fig. 3H ; Class S).
Function and Pharmacology of 5-HT 2 Pan
We next sought pharmacological tools that would allow us to characterize the roles of the two previously cloned Panulirus 5-HT receptors in generating the 5-HT response. The Panulirus 5-HT 2 Pan receptor has been shown to respond specifically to 5-HT and to couple to the inositol phosphate (IP) signaling pathway when stably expressed in HEK cells (Clark et al. 2004) . In this study we transiently expressed 5-HT 2 Pan in HEK cells and measured IP release in response to amines and putative pharmacological agents. Non-transfected parental HEK cells did not respond to 5-HT in the IP assay. IP levels showed a dose dependent increase in response to 5-HT in cells expressing 5-HT 2 Pan with an EC 50 of 52nM (Fig. 4A , Table 1 ).
In order to determine a pharmacological profile for 5-HT 2 Pan we tested a suite of putative agonist and antagonist drugs. In an initial overview, all drugs were tested at 10 -3 M (agonists) or 10 -5 M (antagonists). Agonists that produced a significant increase in IP levels in transfected but not parental lines, and antagonists that inhibited the 5-HT induced increase but had no effect on the parental lines, were then used to generate dose response curves. Typical dose response curves for agonists and antagonists are shown in Fig. 4A . From these curves we determined the potency and efficacy of each drug. The EC 50 or IC 50 are measures of the potency of a drug and reflect its binding affinity at the receptor. Because the maximum effect, or efficacy, achieved by any drug is dependent on the number of receptors expressed, we ran a parallel dose-response curve for 5-HT in every experiment and normalized all drug efficacies to the maximum 5-HT response, set at 100%. These data are summarized in Tables 1 and 2 .
The following agonist potency rank profile was determined for 5-HT 2 Pan : 5-HT > methysergide > 8-OH-DPAT > 2-Me-5-HT > MeOTryp > -Me-5-HT > DOI > 5-CT. While most agonists achieved above 75% of 5-HT activation levels, methysergide and DOI were only partial agonists of 5-HT 2 Pan with efficacies of less than 50% of the 5-HT effect. No change in IP level was detected after application of 10 -3 M N-acetyl-5-HT, quipazine, or mCPP. None of the drugs had significant effects on non-transfected parental HEK cells.
The rank potency of effective antagonists at 5-HT 2 Pan was (+)butaclamol > ritanserin > methiothepin > cinanserin > clozapine. Ritanserin and (+)butaclamol, however, were only partially effective in inhibiting activation of 5-HT 2 Pan by 5-HT even at the highest antagonist concentration. Of the antagonists tested, ketanserin, spiperone, prazosin, (-)butaclamol, gramine and atropine had no effect at 10 -5 M. Putative antagonists had no effect on non-transfected parental HEK cells.
Function and Pharmacology of 5-HT 1 Pan
We have functionally characterized crustacean 5-HT 1 Pan receptors using a heterologous expression system and demonstrated that these receptors negatively couple with cAMP (Spitzer et al., 2008) . In this expression system the 5-HT 1 Pan gene is stably integrated into the genome of 293-TR-5-HT 1 Pan cells, but the cells do not express the receptor until they are chemically induced to do so. Thus, the negative control for this assay is not parental cells, but rather, noninduced 293-TR-5-HT 1 Pan cells.
We tested the same suite of potential agonists as above on induced and non-induced 293-TR-5-HT 1 Pan cells. Fig. 4B shows the effect of increasing concentrations of 5-HT 1 Pan agonists on cAMP levels in 293-TR-5-HT 1 Pan cells that were or were not induced to express 5-HT 1 Pan 18-20hr prior to performing the cAMP assay. Though their potencies (EC 50 ) and efficacies (% 5-HT effect) were different, both 5-HT and mCPP elicited a dose dependent inhibition of forskolin stimulated cAMP accumulation in induced, but not non-induced cells. Some agonists (DOI, 2-Me-5-HT, quipazine) had significant effects on non-induced 293-TR-5-HT 1 Pan cells, and could therefore not be tested on induced cells (indicated as Bkd in Table 1 ). For each of the remaining drugs, the EC 50 and the relative efficacy were calculated from dose response curves similar to those shown in Fig. 4B . In this way we generated an agonist profile for the receptor that is summarized in Table 1 . The relative potencies of functional agonists at 5-HT 1 Pan were: 5-HT > methysergide > -Me-5-HT > 5-CT > MeOTryp > 8-OH-DPAT > mCPP. 5-HT 1 Pan did not respond significantly to 10 -3 M N-acetyl-5-HT. We also tested antagonists for their ability to inhibit 5-HT 1 Pan activation by 5-HT ( Table  2 ). The antagonist (10 -5 M) was applied ten minutes prior to 5-HT and forskolin stimulated cAMP levels were determined. Twenty nine drugs were tested (the suite tested on 5-HT 2 Pan and eighteen additional drugs). Seven antagonists (clozapine, methiothepin, S(-)propanolol, metergoline, cyproheptadine, SCH23390, S(-)eticlopride) had significant effects on non-induced 5-HT 1 Pan cells and could therefore not be tested for activity on induced 5-HT 1 Pan cells (indicated as Bkd in Table 1 ). None of the remaining 22 drugs was able to significantly block the inhibition of cAMP accumulation resulting from 5-HT activation of 5-HT 1 Pan , even when low levels (5x10 -8 M) of 5-HT were used.
Identification of drugs to differentiate 5-HT 2 Pan and 5-HT 1 Pan .
Several drugs whose action could differentiate between 5-HT 2 Pan and 5-HT 1 Pan were identified (Tables 1 and 2 ). The agonist mCPP activates 5-HT 1 Pan but not 5-HT 2 Pan . Several 5-HT 2 Pan antagonists that did not block 5-HT 1 Pan receptors were also identified: (+)butaclamol, cinanserin and ritanserin. We next used these drugs on the native system to study the role of the 5-HT 2 Pan and 5-HT 1 Pan receptors in modulating pyloric cf.
Blocking the 5-HT 2 Pan transduction cascade significantly alters temporal phases 2 and 3 of the 5-HT response
Figs. 1-3 illustrate that the 5-HT induced change in cf could could be divided into 3 temporal phases (Ph1, Ph2, Ph3) and could vary with the preparation (e.g., Classes F, S & NC). The mechanisms underlying this temporal progression and preparation-to-preparation variability were unknown. We next set out to determine whether 5-HT 1 Pan and 5-HT 2 Pan receptors were components of the 5-HT response system that controlled cf, and if so, how these components varied with time and across preparations.
We first examined the contribution of 5-HT 2 Pan receptors to 5-HT modulation of cf. The antagonists (+)butaclamol and cinanserin block 5-HT activation of 5-HT 2 Pan but not 5-HT 1 Pan receptors (Table 2) ; therefore, we applied cinanserin or (+)butaclamol with 5-HT (Fig. 5) . Unfortunately, cinanserin and (+)butaclamol could not be used on the same preparation because their antagonistic effects did not wash out. This also prevented us from reversing the order of application (i.e., we could not perform 5-HT plus antagonist followed by 5-HT alone). Nevertheless, it was clear from qualitative observations (e.g., compare Figs. 5A vs. 5B) and quantitative measurements (see below) that these drugs produced comparable results. Additionally, preliminary experiments using the 5-HT 2 Pan antagonist, ritanserin (Table 2) Representative experiments are shown for cinanserin (Fig. 5A, n=8 ) and (+)butaclamol (Fig. 5B, n=22 ). In these serial experiments, modulatory input was blocked with sucrose on the stn and the preparation stabilized in a basal cycling state for 1hr. Baseline measurements of cf were obtained immediately before a 5min application of 10µM 5-HT (labeled 5-HT baseline in Fig. 5 ). 5-HT application was followed by a 1hr wash. Since baseline increased and remained steadily elevated throughout these experiments (Figs. 2D&3A) , a new baseline (labeled antagonist baseline in Fig. 5 ) was measured immediately before application of antagonist and represented the last ten cycles of the 1hr wash. Antagonist (10µM) was applied alone for 5min and then together with 10µM 5-HT for 5min followed by a 1hr wash. Antagonists alone had no significant effect on cf (mean cinanserin induced change in cf=-0.5+1.5%, p>0.7, n=8; mean (+)butaclamol induced change in cf =0.2+1.4%, paired t-test p>0.8, n=22).
Regardless of the network's initial response to 5-HT (e.g. F, S, NC), in approximately 91% of the experiments 5-HT 2 Pan antagonists consistently altered the 5-HT induced change in cf in two respects. First, the antagonist abolished the rise in cf usually observed during temporal phase 2 of the 5-HT response (see Fig 3C) . In the presence of 5-HT alone, cf increased during phase 2 relative to phase 1 in 26 of 30 experiments (average cf {phase 2 peak -phase 1 nadir}=0.17+0.04Hz; paired t-test for Ph2 peak vs. Ph1 nadir p<10 -3 , n=30). However, in the presence of 5-HT plus antagonist, the phase 2 peak was no longer significantly different from phase 1 nadir (average cf {phase 2 peak-phase 1 nadir=-0.03+0.05Hz; paired t-test for Ph2 peak vs. Ph1 nadir p>0.56, n=30). Second, whereas 5-HT alone produced no significant change in mean steady-state 5-HT cf relative to baseline (see Fig 1D) , 5-HT plus antagonist produced a significant decrease in mean steady-state 5-HT cf relative to baseline (mean steady-state cf in 5-HT plus antagonist/baseline=0.67+0.05, paired t-test p<10 -7 , n=30). When considered in light of the fact that 5-HT 2 Pan receptors have been localized to the STG neuropil (Clark et al. 2004) , these data suggest that 5-HT 2 Pan receptors are part of the 5-HT response system that modulates cf in most preparations. However, because pharmacology across paralogs within a class (e.g. 5-HT 2 & 5-HT 2 ) is often conserved (Saudou et al. 1992) , we cannot conclude that the antagonists are acting solely on 5-HT 2 Pan receptors. For this reason we will refer to the component blocked by 5-HT 2 Pan antagonists as the 5-HT 2 Pan -like component.
In Fig. 5 , application of antagonist plus 5-HT appeared to restore the preparation to its original, pre-5-HT cf (i.e., 5-HT baseline). Based on this figure one might speculate that the second drug application removed a long-lasting change initiated by the first 5-HT application. Several pieces of evidence suggest that this is not the case: First, the change in cf elicited by antagonist plus 5-HT did not vary according to whether the drugs were applied directly to a naive preparation (n=5) or followed a prior exposure to 5-HT and a 1hr wash (Fig. 5) , and the drug induced change from baseline resulting from these two types of applications were not significantly different (p=0.77). Second, there was no correlation between "5-HT baselineantagonist baseline" and "antagonist baseline -cf in 5-HT plus antagonist," (linear regression, p>0.8, n=30). Third, there was no significant correlation between 5-HT baseline and steady state cf in 5-HT plus antagonist (linear regression, p=0.07, n=30).
At least two highly variable components comprise the 5-HT response system
The experiments represented in Fig. 5 suggested that at least two independent components comprised the 5-HT response system that regulated cf: a 5-HT 2 Pan -like component that was lost upon antagonist application and a non-5-HT 2 Pan component that remained upon antagonist application. We selected 24 of the original 30 antagonist experiments that were relatively periodic throughout the recording interval and computationally isolated their 5-HT 2 Pan -like components. Importantly, we have shown that 5-HT receptors respond in a like manner to serial 5min applications of 5-HT spaced at 1hr intervals (Fig. 3B) . Thus, for each experiment we could approximate and visualize the 5-HT 2 Pan -like component of the 5-HT induced change in cf as a difference trace obtained by subtracting the cf plots acquired in the presence vs. absence of antagonist, as described in Materials and Methods. A subset of our 24 analyses that reflects the range of observed variability is shown in Fig. 6 . This figure makes the point that the 5-HT induced change in cf (blue trace in left panels, termed blue trace average, see Materials and Methods) is composed of at least two separable and highly distinct components, a 5-HT 2 Pan -like component (gold trace in right panels, termed difference trace, see Materials and Methods) and a non-5-HT 2 Pan component (green trace in left panels, termed green trace average, see Materials and Methods), which can perhaps be further subdivided (see below). Note that any synergistic effects resulting from the interaction between the components would be lost upon application of the 5-HT 2 Pan antagonist, and therefore attributed solely to the 5-HT 2 Pan -like component. Unfortunately, despite a considerable effort, we could not identify specific 5-HT 2 Pan agonists to complement the antagonist studies. Figure 7 shows the average response for all 24 preparations ( Fig. 7A-C ) and a quantification of the variability between the 24 preparations ( Fig. 7 D-F) . The mean of the 24 individual blue trace averages is plotted in Fig. 7A . The three previously described temporal phases of the 5-HT response are demarcated. To quantify the response for an individual preparation, we measured the change from baseline during each of the 3 temporal phases as described in Materials and Methods. The 24 individual preparations are plotted as 24 blue circles in 3 dimensional space in Fig. 7D . Each axis represents one of the three temporal phases. For a given axis (temporal phase), numbers > or < 1 represent an increase or decrease in cf relative to baseline, respectively. The larger the change, the further the datum is from the number 1. The means and the individual variability for the non-5-HT 2 Pan component (Fig 7B &7E, respectively) and the 5-HT 2 Pan -like component (Fig. 7C & 7F, respectively) are similarly plotted. There were statistically significant correlations between the amplitudes of the changes in cf relative to baseline during the three temporal phases (e.g. phase 1 cf/baseline vs. phase 2 cf/baseline). It appeared that the larger the decrease in cf during phase 1, the smaller the increase over baseline in phases 2 and 3 (p<0.05, Correlation analysis, Prism). This was true for both individual components as well as the total response.
Whereas the 5-HT 2 Pan -like component was largely responsible for a delayed, sustained increase in cf relative to baseline (Fig. 7C) , there was a remarkable amount of preparation-topreparation variability in this component (Figs. 6&7F) . In 2 of the 24 experiments, the 5-HT 2 Pan -like component was comparatively small or absent (e.g., Fig. 6G ). In the remaining 22 experiments the difference trace was typically biphasic, such that 5-HT 2 Pan -like receptor activation generally produced an initial decrease in cf during temporal phase 1, followed by a slower increase that peaked during temporal phase 2 and attained a steady state by 5min (i.e., phase 3). In some experiments, however, one or more of these attributes of the 5-HT 2 Pan -like component was absent. For example, the trough in temporal phase 1 was missing in the experiment shown in Fig. 6A , and both the trough and steady state phases were missing in experiment 6D. Despite this variability, the mean nadir in phase 1 and peaks in phases 2 and 3 were significantly different than baseline (mean cf/baseline+stdev=0.76+0.43Hz, 1.51+0.33Hz, and 1.26+0.45Hz; paired t-tests p<0.05; n=24). Note that the calculated mean phase 1 nadir for the 5-HT 2 Pan -like component (-0.24) differs from that which is graphed in Fig 7C (>-0.1) . This is because the exact time of the nadir varied with each preparation (e.g., see Fig 6) so that when all difference traces were averaged, the large nadirs seen in individual preparations were smoothed away in the average and thereby obscured. This is also true to a lesser extent for the phase 2 peak.
The non-5-HT 2 Pan component produced an immediate and sustained decrease in cf relative to baseline (Fig.7B) . In some cases the initial decrease in cf could be followed by a small, gradual increase (e.g., Figs. 6C&G). In 3 of the 24 experiments the non-5-HT 2 Pan component was absent (e.g., Fig. 6B ). In other experiments there was an obvious shift in the time constants of decay between 30 seconds and 2 minutes (e.g., Fig. 6A ), and in 6 of 24 experiments there was an obvious increase in cf during this period. Whereas an unknown element may mediate the increase, it is also possible that the 5-HT 2 Pan -like component was incompletely blocked by antagonist in these preparations. Though variable, the mean decrease in cf relative to baseline for the non-5-HT 2 Pan component was statistically significant during all 3 temporal phases (mean cf/baseline+stdev=0.79+0.19Hz (phase 1), 0.77+0.31Hz (Phase 2) and 0.71+0.22Hz (Phase 3), n=24, paired t-tests p<10 -3 ). It might be questioned whether some or all of the variability in the response to 5-HT results from the response being sensitive to absolute cf immediately before modulator application. For example, in the crab STNS, the crustacean cardioactive peptide (CCAP) hormone consistently increased cycle period during a relatively fast gastric mill rhythm but produced inconsistent results during slower rhythms (Kirby and Nusbaum 2007). Figs. 1C&2 suggest that the steady-state 5-HT effect is not sensitive to baseline cf. We further examined the cycle period dependent effects of 5-HT in all phases of the 5-HT response and for the 2 individual components by performing correlation analyses (Prism, GraphPad) on measurements from these 24 preparations. Baseline frequency vs. the 5-HT induced change in cf [i.e. (cf in 5-HT)/baseline] for each of the three temporal phases in each of the 24 preparations was plotted. None of the three correlations were significant (p> 0.05). We performed similar analyses for each temporal phase of the non-5-HT 2 Pan component [i.e., antagonist baseline vs. (cf in antagonist+5-HT)/antagonist baseline] and the 5HT 2 Pan -like component (baseline vs. difference trace measurements) and found no significant correlations (p> 0.05 in all cases). Thus, the actions of 5-HT appear to be independent of absolute cf in all three temporal phases of the response, even at the level of individual components.
The sum of the two opposing and variable components determines the Class
As discussed at the beginning of Results, preparations could be divided into 3 Classes depending upon whether cf increased (F), decreased (S) or remained unchanged (NC) relative to baseline after 5min in 5-HT. Comparisons of the 3 Classes with a one way ANOVA followed by a Tukey posthoc test demonstrated that all Classes were significantly different from each other at steady state (Table 3 , last 3 columns, phase 3). Interestingly, one way ANOVAs indicated that there were no significant differences in cycle frequencies between these Classes prior to 5-HT application (p>0.6 for intact preparations; p>0.85 for preparations with a sucrose block on the stn, data not shown). These data indicate that circuits that do not appear to be functionally different (e.g., similar cycle frequencies across individuals) can show different responses to the same modulatory challenge.
The existence of the 3 Classes could be due to Class-specific differences in the components of the 5-HT response system (e.g., the 5-HT 2 Pan -like component that increases cf is always large in Class F and small in Class S). To address whether or not there were fundamental differences in the 5-HT 2 Pan -like component between the three Classes, we used one-way ANOVAs to compare the changes in cf produced by 5-HT 2 Pan -like receptor activation during a given temporal phase. Table 3 shows that there were no significant differences in the 5-HT 2 Panlike component between the different Classes for any temporal phase. This can also be seen by examining Fig. 6 . For example, the preparations in Figs. 6C and 6F belong to Classes F and S, respectively, and yet they have highly similar 5-HT 2 Pan -like components. Comparable analyses indicated that neither were there statistically significant differences in the non-5-HT 2 Pan component between the Classes (Table 3, Fig 6) . In sum, the two components displayed preparation-to-preparation variability within a Class; however, when all preparations were considered, the set of components in one Class was no different than in another, and a given component (e.g., producing large vs. small change from baseline) was equally likely to be found in any of the three Classes.
How are different Classes of responses produced from the same set of components? Analyses of individual preparations suggested it was the balance of the two components that determined the Class. At steady state 5-HT 2 Pan -like>non-5-HT 2 Pan for Class F, non-5-HT 2 Pan >5-HT 2 Pan -like for Class S and non-5-HT 2 Pan =5-HT 2 Pan -like for Class NC. Fig. 6 shows that the 5-HT induced change in cf was the sum of two highly variable components. Initially both components produced a decrease in cf. The minima of the two components were not necessarily coincident. Whereas the non-5-HT 2 Pan component continued to decrease throughout phase 1, the 5-HT 2 Pan -like component reached its nadir and then began to rise late in phase 1. From this point on the two components produced opposing changes in cf, and their balance appeared to determine whether 5-HT ultimately produced a net increase, decrease or no change in cf relative to baseline. This is most clearly seen by comparing Figs. 6B, 6E and 6F. One of the largest 5-HT 2 Pan -like components is observed in Fig. 6F (~0.9Hz increase at steady state), but in this experiment 5-HT produced a 32% net decrease in cf at steady-state, because the non-5-HT 2 Pan component was even larger. The experiment shown in Fig. 6B has the smallest 5-HT 2 Pan -like component (~0.15 Hz increase at steady state), but 5-HT produced a significant 14% net increase at steady state, because the non-5-HT 2 Pan component was absent. Fig. 6E shows an intermediate 5-HT 2 Pan -like component (~0.4 Hz increase at steady state), yet 5-HT had no net effect on cf in this experiment because the non-5-HT 2 Pan component was equally large. Thus, the steady state 5-HT response is determined by the sum of opposing components.
This idea that each Class represents a different balance of components is further substantiated by an examination of the means within a Class. In Class F the average 5-HT 2 Panlike component was approximately 1.6 times larger than the average non-5-HT 2 Pan component at steady state (mean % change from baseline cf at steady state produced by each component: 5-HT 2 Pan -like=44+8% increase, non-5-HT 2 Pan =27+8% decrease, n=11), but the opposite was true for class S preparations (mean % change from baseline cf at steady state produced by each component: 5-HT 2 Pan -like=8+12% increase, non-5-HT 2 Pan =38+9% decrease, n=7). Further, using the aforementioned measurements of the 5-HT induced change from baseline during phase 3 (see Fig 7E-F) we obtained a ratio of the components for each preparation at steady state (phase 3 5-HT 2 Pan -like component/phase 3 non-5-HT 2 Pan component). A Kruskal-Wallis followed by a Dunnett's post-hoc test showed that the ratios were significantly different for Classes F and S (Table 4) . Together these analyses suggest that the different Classes represent a change in the balance of opposing components of the 5-HT response system.
5-HT 1 Pan -like receptors mediate a slow increase in cf
We next examined the role of 5-HT 1 Pan receptors in mediating the 5-HT effect on cf. Because we were unable to identify specific antagonists for 5-HT 1 Pan , we used an agonist, mCPP, to investigate the role of this receptor. While mCPP is a relatively weak agonist of 5-HT 1 Pan , it was the only one tested that had no activity at 5-HT 2 Pan in cell culture (Table 1) . This criterion was important since 5-HT 2 Pan activation contributed significantly to 5-HT induced changes in cf (Figs. 5-7) . In these studies 100µM mCPP was used to activate 5-HT 1 Pan receptors, because 10-50µM mCPP was ineffective (Zhang and Harris-Warrick 1994; Spitzer unpublished). Given the high concentration of mCPP used, we cannot rule out the action of this drug at other receptors. Thus, the component of the 5-HT response system identified by these experiments will be referred to as the 5-HT 1 Pan -like component. Fig. 8A shows an example of a typical mCPP experiment. In this preparation a 5min, 5-HT (10µM) application slowed cf. 5-HT application was followed by a 1hr wash and a 5min application of 100µM mCPP. After a further 1hr wash, (+)butaclamol, a 5-HT 2 Pan antagonist, was applied for 5min followed by butaclamol+mCPP. In some experiments the order of 5-HT and mCPP applications were reversed.
Application of mCPP caused an increase in cf in all preparations regardless of the 5-HT effect. Figure 8B illustarates that the mean steady state cf, measured as the average during the last minute of mCPP application, significantly increased by 33+4.5% relative to baseline. The time course of the response varied so that the peak effect was reached between 1-5min. In 7 of 9 experiments, a steady state was reached within 5min, and in the remaining 2 preparations the cf continued to increase throughout the 5min 5-HT application. The mCPP induced increase was not blocked by (+)butaclamol, and its magnitude varied across preparations by a factor of 5. After a 1hr wash out of mCPP, there was an increase in cf relative to baseline, similar to preparations exposed to 5-HT. As shown in Fig 2D&3A, this increase could be due to mCPP independent phenomena. Reversing the order of 5-HT and mCPP applications did not alter the observed effects.
These data suggest that 5-HT 1 Pan -like receptors could contribute a small, gradual increase in cf to the non-5-HT 2 Pan component of the 5-HT response system. Unfortunately, the lack of a specific 5-HT 1 Pan antagonist prevented us from testing this hypothesis further. However, if this hypothesis is true, then there must be at least one additional subcomponent that mediates a decrease in cf and opposes both the increases mediated by 5-HT 1 Pan -like and 5-HT 2 Pan -like receptors at steady state.
5-HT effects on VD could underpin the decrease in cf associated with the non-5HT 2 Pan component
In the intact system, VD is thought to regulate cf via its rectifying electrical junctions with the pacemaker kernel. It was previously shown that VD acts to increase cf, most likely by injecting positive current into the AB/PD pacemaker during the depolarizing phase of the pacemaker oscillation (Weaver and Hooper 2003). VD's governance of cf is state dependent, such that VD's influence is greatest at slower cycle frequencies (e.g., < 1.0), which are typical for the deafferented preparations studied here ( Fig. 1D ; average baseline cf = 0.77+0.4Hz, n=44). In the absence of 5-HT, VD is active in deafferented preparations (Fig. 1B , mvn trace in middle panels); thus, it is likely that VD provides an accelerating influence on cf under these experimental conditions. Presumably, phenomena that inhibit VD and/or reduce its electrical coupling with the pacemaker kernel will diminish VD's accelerating influence on the pacemaker, and thereby slow cf. It was previously shown that (1) 10µM 5-HT reduces the electrical coupling between VD and the pacemaker kernel by ~50% (Johnson et al. 1993) ; (2) (Figs. 9B-C) ; and application of mCPP, a 5-HT 1 Pan agonist, also did not alter the firing rate of the VD neuron (Fig. 8C) . Thus, neither 5-HT 2 Pan -like nor 5-HT 1 Pan -like receptors mediate the 5-HT induced hyperpolarization of VD. Together these data suggest that 5-HT effects on VD could produce the rapid and sustained decrease in cf associated with the non-5HT 2 Pan component of the 5-HT response system.
5-HT 2 Pan -like receptors do not mediate the excitation of IC
The activity of the IC cell is visible on many mvn recordings. Like LP, IC was silent after the sucrose block was applied. However, consistent with previous studies (Flamm and Harris-Warrick 1986a) , in some preparations 5-HT elicited spikes in the IC. The 5-HT 2 Pan antagonists had no effect on 5-HT induced excitation of IC in any preparation regardless of whether or not 5-HT produced an increase (n=8, data not shown) or decrease in cf (n=5, not shown). Thus, 5-HT 2 Pan -like receptors do not mediate the 5-HT induced excitation of IC.
Discussion
In order to reconcile the emerging principles of plasticity (Davis 2006) and metamodulation (Katz and Edwards 1999) with network stability (discussed in Marder and Goaillard 2006 and in Nowotny et al. 2007) , we have deconstructed the 5-HT response system that controls pyloric network cycle frequency (cf). We found that the system was composed of at least three separable components. Some of the components produced opposing changes in cf, and each component showed a great deal of preparation-to-preparation variability. In the absence of all other modulatory inputs, this system produced a variable response to 5-HT. Ultimately, the balance of opposing components determined whether 5-HT produced an increase, decrease or no change in cycle frequency.
The three components of the 5-HT response system
Our data suggest that there are at least three distinct components of the 5-HT response system controlling cf. The first component is associated with a 5-HT 2 Pan -like transduction cascade(s). This component is characterized by an initial decrease followed by a steady state increase in cf. The biphasic response most likely reflects activation of distinct signaling pathways on different time scales. 5-HT 2 Pan receptors couple with Gq to activate phospholipase C and ultimately increase the activity of protein kinase C in HEK cells (Clark et al. 2004) . In mammals, activation of the 5-HT 2 family can additionally stimulate Phospholipase A 2 , NO synthesis, and the MAP Kinase cascade (Nebigil et al. 2001) . It is not clear whether the mechanism giving rise to the bimodal effect involves one or a combination of these (or other) signaling pathways.
Differential localization of the receptor could also contribute to bimodality. Arvanov et al. (1999) showed that 5-HT 2A receptors generated a biphasic response in rat medial prefrontal cortex because they were located both pre-and post-synaptically. The subcellular compartmentalization of 5-HT 2 Pan receptors within the synaptic neuropil of the STG is not known. All STG neurons express 5-HT 2 Pan , and this receptor is found throughout the synaptic neuropil, but not in the plasmalemma surrounding the soma or large diameter neurites (Clark et al. 2004 ). We previously demonstrated that 5-HT 2 Pan receptors were located on distal axon terminals in PD and PY cells (Clark et al., 2004) . Here we have shown that 5-HT 2 Pan receptors do not mediate 5-HT inhibition of VD or excitation of IC; hence, 5-HT 2 Pan receptors may also be localized to the peripheral regions of these neurons. 5-HT is known to regulate multiple conductances in the AB pacemaker neuron, ultimately enhancing its excitability and synaptic output to increase steady-state cf (Flamm and Harris-Warrick 1986b; Harris-Warrick and Flamm 1987; Johnson et al. 1993; ) . Furthermore, the 5-HT 2 Pan antagonist, cinanserin, blocks 5-HT elicited AB/PD bursting in the crab, Cancer borealis, (Zhang and Harris-Warrick 1994) . The most parsimonious interpretation of all the data is that the 5-HT 2 Pan -like receptors responsible for increasing steady-state cf reside in the AB synaptic neuropil. However, it is also possible that these receptors reside on the terminals of modulatory projection neurons, and that some of the varied effects of 5-HT on cf are mediated by local interactions between these terminals and their targets (Coleman and Nusbaum 1994; Coleman et al. 1992; Goaillard et al. 2004) .
The second component of the 5-HT response system is mediated by a 5-HT 1 Pan -like transduction cascade. This component produces a small, gradual increase in cf. 5-HT 1 Pan receptors couple with Gi/o in HEK cells to decrease cAMP (Spitzer et al., 2008) . The location of this receptor is presently unknown, though it is unlikely to be found in the VD synaptic neuropil as the 5-HT 1 Pan agonist did not affect VD activity.
The third component of the 5-HT response system results in an immediate and sustained decrease in cf, but the receptors involved are currently unknown. The three uncharacterized GPCRs in the arthropod genome are unlikely candidates because they are not homologous to known 5-HT receptor subtypes (Clark and Baro 2007) . We have shown here that this component is independent of 5-HT 1 and 5-HT 2 -like receptors. The only remaining known arthropod 5-HT receptor is 5-HT 7 which couples with Gs (Schlenstedt et al. 2006) .
Our results are consistent with the notion that the third component is at least partially localized to the VD follower neuron. However, this idea is called into question by Ayali and Harris-Warrick (1999) , who showed that when modulatory inputs were intact, the 5-HT induced change in cf was not significantly different between the isolated AB neuron, the isolated AB-PD pacemaker kernel, and the intact network. This suggested that 5-HT acted solely on the AB neuron to control cf. Interestingly, in their hands 5-HT always produced an increase in cf. A major difference between the two studies was the presence (Ayali and Harris-Warrick) vs. the absence (this manuscript) of descending modulatory inputs. It is noteworthy that when modulatory inputs to the network are intact (i.e., non-deafferented preparation), LP and VD are both active and have reciprocal effects on cf (Weaver and Hooper, 2003) , and that 5-HT acts directly to hyperpolarize both LP and VD to the same extent (Flamm and Harris-Warrick, 1986b) . Conversely, in our deafferented preparation, LP is hyperpolarized prior to 5-HT application. Thus, deafferentation may remove a fourth component of the 5-HT response system that resides on the LP and produces an increase in cf.
Sources of component variability
Our results are consistent with previous studies suggesting that similar network activity may be produced from disparate cell and network parameters (Prinz et al. 2004; Bucher et al. 2005) . The most obvious sources for variability in the response to 5-HT are the proteins comprising the transduction cascades. Receptor function and/or expression can be statedependent (Ango et al. 2001; Bockaert et al. 2003; Clark and Baro 2007) (Cirelli and Tononi 2004; Dwivedi et al. 2005 ) (Anji et al. 2001 Riad et al. 2001; Wohlpart and Molinoff 1998; Spitzer et al. 2005 ). In addition, one or more downstream components of the 5-HT signal transduction cascades could vary. For example, alterations in the signaling pathway could occur at the level of the final target. In this regard, ion channel activity and expression in pyloric neurons is known to vary significantly across individuals (Golowasch et al. 1999; Schulz et al. 2006; 2007) , and neuromodulatory input can regulate expression of ionic currents and channels over the long-term (Khorkova and Golowasch 2007; Mizrahi et al. 2001) .
Synaptic plasticity may also contribute to variability between preparations. 5-HT alters the strengths of glutamatergic synapses between the pacemaker kernel and follower LP and VD neurons, as well as electrical coupling between VD and the pacemaker kernel (Johnson and Harris-Warrick 1990; Johnson et al. 1993 Johnson et al. , 1994 Johnson et al. , 1995 . In preliminary experiments, suppression of glutamatergic synapses did not prevent a variable 5-HT response. To our knowledge, the degree of preparation-to-preparation variability in the strength of electrical coupling between VD and the pacemaker kernel is presently unknown.
State dependent effects that are independent of changes in gene expression and/or cell morphology could also account for the variability observed here. Many effects of G protein coupled receptors are made manifest only under certain conditions. For example, in prefrontal cortex neurons, activation of dopamine type 1 receptors (D1) significantly reduced EPSP decay time and integral at membrane potentials near spike threshold (i.e., upstate), but not at more hyperpolarized potentials (i.e., downstate). This is because D1 activation altered the phosphorylation state of Na + channels (Rotaru et al. 2007 ) at all membrane potentials (Carr et al. 2003) ; which altered voltage-dependent slow inactivation (Carr et al. 2003; Chen et al. 2006) , such that Na + channel availability was reduced only in the upstate. Working on STG neurons, Nargeot (2003) demonstrated that the long term effect of a neuromodulator could be consistent at the molecular level, and yet evoke opposite changes in neuronal activity depending upon the cell's membrane potential. Similarly, state dependent effects have been observed at the network level. For example, it has been shown that the influence of the same modulatory change (i.e., change in the strength of an identified synapse) can vary according to network cycle frequency (Thirumalai et al. 2006) .
In sum, the variability we observed could be explained by a variety of mechanisms ranging from changes in gene expression to changes in ion channel phosphorylation states that alter membrane potential. With regard to the latter, it is important to note that the effects of endocrine and paracrine modulation can last well beyond the removal of their inputs (Blitz et al. 2008; Di Prisco et al. 1997; Turrigiano and Selverston 1990; Wood et al. 2004 ). This depends, in part, upon the mechanisms for removal of neuroactive substances outside the synapse (Coleman et al. 1994; Wood and Nusbaum 2002) , as well as the stability of the change induced by the modulator. Since we examined 5-HT actions roughly 2-4 hours after removing hormonal inputs, and only one hour after removing synaptic and paracrine modulatory inputs, their long-term actions could still be in effect.
Stability vs. variability of neuromodulatory effects on STNS circuits
In direct contrast to our findings, there exists a vast literature (too large to fully cite here) documenting the reproducibility of neuromodulatory actions on STNS circuits. This apparent discrepancy is easily explained for work examining modulation by projection neurons onto circuit neurons (e.g., Saideman et al. 2007a; Stein et al. 2007 ) and/or extrinsic inputs onto these projection neurons (e.g., Beenhakker et al. 2007; Blitz et al. 2008 ). Since these types of studies usually employ an intact preparation (i.e., non-deafferented), it may be that reproducibility is maintained through stabilizing mechanisms involving additional modulatory inputs and/or feedback from STG neurons to input neurons (Coleman et al. 1995; Coleman and Nusbaum 1994; Wood et al. 2004) . The existence of these mechanisms was implied in our studies by the fact that when we removed modulatory input, cycle frequency drifted over time. Additionally, projection/sensory neuron transmission can be highly targeted so that only one or a few components of a multi-component system are activated by a given modulator (e.g., only the excitatory or the inhibitory components). Likewise, the apparent discrepancy is understandable for studies that bath apply neuroactive substances to non-deafferented preparations (e.g., Krenz et al. 2000; Szucs et al. 2005) ; although the bath applied modulator would not be localized, the aforementioned stabilizing feedback mechanisms could still be in effect.
Considering only studies in which modulators were bath applied to deafferented preparations, one observes a large literature reporting reproducible effects of modulators on isolated ionic currents (e.g., Kloppenburg et al. 2000; Peck et al. 2006; Peck et al. 2001; Swensen and Marder 2000) . These results are not inconsistent with our findings. In all of these studies the system was highly reduced to a single current in a synaptically isolated cell. Our work suggests that variability is diminished when examining individual components (e.g. VD inhibition) rather than the interaction of multiple components (e.g., network cf). It should be noted that in most studies of modulatory effects on ionic currents, individual differences in time courses and amplitudes could not be assessed, because averages rather than individual responses were reported.
If we consider only those studies that involved bath application to deafferented preparations and that reported on cycle frequency, we find a few reports of variable neuromodulatory effects (e.g., Beltz et al. 1984; Saideman et al. 2007b) ; however, the majority of studies suggest that a given neuroactive substance reproducibly altered cycle frequency (e.g., Christie et al. 2006; Goaillard et al. 2004; Perez-Acevedo and Krenz 2005; Stemmler et al. 2007 ). Again, a lack of individual variability could not be verified due to the use of averages. One important difference between many of these studies and ours was that lower concentrations of a neuroactive substance were often employed. This could account for the disparate findings, because lower concentrations may activate fewer system components. For example, the EC 50 for 5-HT at 5-HT 1 Pan is nearly an order of magnitude lower than that at 5-HT 2 Pan ; thus, at one extreme the 5-HT 1 Pan component might act alone, whereas at the other extreme both components could be maximally activated.
In sum, the paucity of reports on variable modulatory effects is intriguing. It might suggest that the 5-HT response system is more plastic than most neuromodulatory systems. Alternatively, it may be that variability in neuromodulatory response systems has been highly underestimated, perhaps due to reporting procedures and/or the use of techniques that examine individual components rather than their interactions.
Summary
It is becoming increasingly evident that variability in neuronal modulatory systems and networks is often the rule rather than the exception. In the absence of all other modulatory inputs, a given modulatory challenge will not have consistent actions on a cellular or circuit parameter if that parameter is a target of plasticity mechanisms (reviewed in Marder and Goaillard 2006). It is not known if this variability occurs in vivo, and if so, what its functional significance might be. Presumably the variability could reflect adaptations of the stomatogastric network to changing digestive, life cycle or environmental circumstances. Future investigations on this ideal preparation should provide substantial insight into how multiple modulatory, metamodulatory, and plasticity mechanisms are integrated to maintain an adaptive network. and relative efficacies were calculated from dose response curves for each drug. Efficacy is presented as a given drug's ability to activate the receptor compared to the maximum activation obtained from 5-HT (100%). Drugs with differential actions on 5-HT 2 Pan and 5-HT 1 Pan for are shown in bold. n 3 repeated experiments for each drug. IA: drug is inactive, Bkd: drug has background activity on the control non-induced or parental cells and was not tested. Abbreviations: DOI, 2,5-dimethoxy-4-iodoamphetamine; 5-CT, 5-carboxamidotryptamine; 2-Me-5-HT, 2-methyl-serotonin; MeOTryp, 5-methoxytryptamine; -Me-5-HT, -methyl-serotonin; 8-OH-DPAT, (±)-8-hydroxy-2-(di-ndipropylamino) tetralin; mCPP, 1-(m-chlorophenyl)-piperazine. The 5-HT induced change from baseline during each temporal phase was calculated as described in Materials and Methods for each of the 24 preparations represented in Figs 6&7. The means+ SEM are given for the 5-HT 2 Pan -like component, the non-5-HT 2 Pan component and the total response. Significant differences between Classes were determined for the each component or the total response, by comparing preparations using one way ANOVAs followed by Tukey posthoc tests. We only compared data representing the same temporal phase and the same component (i.e., 3 adjacent rows). Note that there were no significant differences in phases 1, 2 or 3 of the 5-HT 2 Pan -like component between Classes F, S and NC. Similarly, there were no significant differences in the non-5-HT 2 Pan component between Classes during temporal phases 1, 2 or 3. However, significant differences between Classes could be observed for the total 5-HT response during all three temporal phases. *, significantly different from Class F, p<0.05; #, significantly different from Class S, p<0.05; †, significantly different from Class NC, p<0.05 Table 4 : Average component ratios at steady state. For each of the 24 individual preparations analyzed and represented in Figs 6&7, the ratio of the 5-HT 2 Pan component to the non-5-HT 2 Pan component was obtained at steady state. The mean of the ratios for each Class is shown in Table 4 . Significant differences in the ratios between the three Classes were determined with a Kruskal-Wallis, followed by a Dunnett's posthoc test. *, significantly different from Class F, p < 0.05; #, significantly different from Class S, p < 0.05. Page 35 
